We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$291B
AUM Growth
+$10.8B
Cap. Flow
-$5.54B
Cap. Flow %
-1.9%
Top 10 Hldgs %
25.57%
Holding
11,136
New
1,911
Increased
3,840
Reduced
3,666
Closed
1,619

Sector Composition

Rank Sector Weight
1 Technology 1.9%
2 Financials 1.28%
3 Communication Services 1.02%
4 Consumer Discretionary 0.99%
5 Healthcare 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOL
10576
DELISTED
Biolase, Inc.
BIOL
-3
Closed -$16K
SCPX
10577
DELISTED
Scorpius Holdings, Inc.
SCPX
-1
Closed -$42K
CACG
10578
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
-29,372
Closed -$831K
AVGR
10579
DELISTED
Avinger, Inc. Common Stock
AVGR
-4
Closed -$14K
CTHR
10580
DELISTED
Charles & Colvard Ltd
CTHR
-1,999
Closed -$27K
MRNS
10581
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-101,548
Closed -$2.25M
NURO
10582
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
-730
Closed -$82K
TAST
10583
PUT
DELISTED
Carrols Restaurant Group, Inc.
TAST
-16,800
Closed -$188K
TRVN
10584
PUT
DELISTED
Trevena, Inc.
TRVN
-23
Closed -$24K
NBSE
10585
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-70
Closed -$6K
NBSE
10586
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-27
Closed -$2K
HTY
10587
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
-20,233
Closed -$180K
CBAY
10588
DELISTED
Cymabay Therapeutics
CBAY
-84,267
Closed -$1.05M
AYX
10589
DELISTED
Alteryx Inc
AYX
-10,641
Closed -$371K
BKCC
10590
DELISTED
BlackRock Capital Investment Corporation
BKCC
-10,639
Closed -$64K
SIEN
10591
DELISTED
Sientra, Inc.
SIEN
-1,013
Closed -$161K
BFIT
10592
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
-20,828
Closed -$364K
SUNW
10593
DELISTED
Sunworks, Inc.
SUNW
-10,228
Closed -$68K
MARK
10594
DELISTED
Remark Holdings, Inc.
MARK
-19,251
Closed -$1.05M
RESP
10595
DELISTED
WisdomTree U.S. ESG Fund
RESP
-82,468
Closed -$2.57M
MRTX
10596
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-47,189
Closed -$1.78M
SRT
10597
CALL
DELISTED
Startek Inc.
SRT
-26,200
Closed -$256K
ONCT
10598
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-357
Closed -$886K
NMRD
10599
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
-1,240
Closed -$56K
XWEB
10600
DELISTED
SPDR S&P Internet ETF
XWEB
-17,683
Closed -$1.35M

Similar funds

Jeff Yass's Q2 2018 Portfolio in Review

As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, up from 1.8% a quarter earlier, followed by Financials and Communication Services.

  • Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
  • Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
  • Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
  • Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
  • Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
  • Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.